HCS
TWST icon

Himension Capital (Singapore)’s Twist Bioscience TWST Stock Holding History

Himension Capital (Singapore)’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$266K Sell
2,581
-2,900
-53% -$189K 0.02% 166
2026
Q1 		$260K Buy
+5,481
New +$246K 0.02% 116

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Himension Capital (Singapore)'s TWST Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its Twist Bioscience (TWST) stake by 53% in Q2 2026, selling an estimated $189K and leaving 2,581 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #166.

Himension Capital (Singapore) first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Himension Capital (Singapore) held 2,581 shares of Twist Bioscience worth $266K as of Q2 2026.
  • Himension Capital (Singapore) sold 2,900 Twist Bioscience shares in Q2 2026, an estimated $189K.
  • Twist Bioscience made up 0.02% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #166 holding.
  • Himension Capital (Singapore) first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.